Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increase of MnSOD expression and decrease of JNK activity determine the TNF sensitivity in bcl2-transfected L929

Y H Kim1, S S Kim

  • 1Department of Biochemistry, College of Science and Bioproducts Research Center, Yonsei University, Seoul, 120-749, Korea.

Cytokine
|May 18, 1999
PubMed
Summary

Bcl-2 protein protects cells from tumor necrosis factor (TNF)-mediated death by increasing manganese superoxide dismutase (MnSOD) and decreasing Jun kinase (JNK) activity. This balance is key to cell survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.

Oncogene·2026
Same author

Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study.

ESMO open·2025
Same author

Effects of hip muscle activation on the stiffness and energy absorption of the trochanteric soft tissue during impact in sideways falls.

Journal of the mechanical behavior of biomedical materials·2022
Same author

Development of a nucleic acid-based lateral flow assay to diagnose ordinary scabies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease.

BMC pulmonary medicine·2021

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor (TNF) is a key mediator of cellular apoptosis.
  • Bcl-2 is an anti-apoptotic protein with a known role in cell survival.
  • Understanding the precise mechanisms of Bcl-2's protective effects is crucial for cancer therapy.

Purpose of the Study:

  • To elucidate the protective mechanism of Bcl-2 against TNF-induced cell death.
  • To investigate the role of manganese superoxide dismutase (MnSOD) and Jun kinase (JNK) in Bcl-2-mediated protection.
  • To analyze the differential responses of Bcl-2 transfected cells under varying treatment conditions.

Main Methods:

  • Transfection of the bcl2 gene into L929 cells to create stable cell lines (clone R1 and R2).

Related Experiment Videos

  • Treatment of transfected and control cells with TNF and/or actinomycin D.
  • Assay of MnSOD activity and JNK activity.
  • Measurement of MnSOD mRNA expression levels.

    • Main Results:

    • Bcl-2 transfected clones (R1 and R2) exhibited resistance to TNF-induced cytotoxicity, with clone R1 showing stronger protection.
    • TNF treatment led to increased MnSOD activity and mRNA expression, and suppressed JNK activity in both R1 and R2 clones.
    • Under combined TNF and actinomycin D treatment, clone R2 became sensitive, showing increased JNK activity, while clone R1 remained resistant.
    • MnSOD activity was undetectable when cells were treated with both TNF and actinomycin D.

    Conclusions:

    • Suppression of JNK signaling and activation of MnSOD are critical components of Bcl-2's inhibition of TNF-mediated cell death.
    • The balance between MnSOD and JNK pathways is a significant factor in the cytoprotection conferred by Bcl-2.
    • These findings provide insights into novel therapeutic strategies targeting cell death pathways in cancer.